• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . The burden of COVID-19 in primary care of Almaty, Kazakhstan, 2021-2022

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Feb 12;15(1):5186.
doi: 10.1038/s41598-025-89707-5. The burden of COVID-19 in primary care of Almaty, Kazakhstan, 2021-2022

Nailya Kozhekenova[SUP] #[/SUP][SUP] 1 2 [/SUP], Sharapat Moiynbayeva[SUP] #[/SUP][SUP] 3 [/SUP], Danilo Jeremic[SUP] 4 [/SUP], Milan Dinic[SUP] 5 6 [/SUP], Pavel Semenov[SUP] 7 [/SUP], Zhansaya Nurgaliyeva[SUP] 8 [/SUP], Shyryn Tolekova[SUP] 9 [/SUP], Anastassiya Miller[SUP] 10 [/SUP], Arshat Smasheva[SUP] 11 [/SUP], Milena Santric Milicevic[SUP] #[/SUP][SUP] 5 [/SUP]



Affiliations
Free article Abstract

Primary healthcare played a crucial role during the COVID-19 pandemic by preventing, timely diagnosing, and referring severe cases to hospitals, as well as monitoring and counseling patients via telemedicine. We used a cross-sectional approach to analyze the severity outcomes of 174,540 COVID-19 cases treated in primary care in Almaty between 2021 and 2022, by age, sex, disease severity, and comorbidities. Outpatients with COVID-19 were mainly aged 30-39 (20.3%) with a mild course (88.9%). Among adults, females predominated (≥ 60-25.5% vs. 19.2%, < 0.001), and among children (0-17), boys - 21.2% vs. 12.1% (p < 0.001). A higher risk for moderate to severe COVID-19 and adverse outcomes was assessed among older adults, particularly those aged 60 and older compared with younger groups (OR = 9.01, 95% CI: 7.72-10.51). Pregnant women had a low risk of severe disease (OR = 0.5, 95% CI: 0.38-0.65). Patients with concomitant disease were at higher likelihood of severe COVID-19 (p < 0.001, OR = 2.51, 95% CI: 1.9-3.15 for obesity, p < 0.001, OR = 1.43, 95% CI: 1.27-1.6 for diabetes mellitus, OR = 1.16, 95% CI: 1.07-1.26 for arterial hypertension, and p < 0.001, OR = 2.5, 95% CI: 2.13-3.02 for chronic obstructive pulmonary disease). The study emphasizes an often-overlooked impact of COVID-19 on primary care, which is essential for improving outpatient care.

Keywords: COVID-19; Comorbidity; Epidemiology; Outpatient; Risk factors.

 
Back
Top Bottom